Zoledronic Acid Shows Improved Clinical Outcomes When Administered Prior to Bone Pain in Men with Advanced Prostate Cancer
According to the FDA approval label, zoledronic acid (Zometa) should be administered to men with advanced prostate cancer once they have failed one hormone therapy type, in other words, once the cancer has become castrate [...]
Denosumab delays the Spread of Prostate Cancer to the Bones, But it Doesn’t Extend Life!
Results from a recent clinical trial indicate that denosumab delayed the spread of prostate cancer metastases bones, however it did not prolong the lives of men. […]
Capesaris™ (GTx-758) Phase II Proof of Concept Trial – A New On the Horizon Drug To Watch
GTx, Inc. this weekend presented results of the Capesaris™ (GTx-758) proof of concept pharmacokinetic-pharmacodynamic (PK/PD) clinical trial treating men with advanced prostate cancer, at the Annual Meeting of the Society of Urologic Oncology. Capesaris is [...]
A Little Humor – Calmness In Our Lives
Recommended For Prostate Cancer Survivors I am passing this on to you because it definitely works, and we could all use a little more calmness in our lives. By following simple advice heard on the [...]
Prostate Cancer Treatment Linked to An Increased Risk of Developing Colon Cancer
What is the primary treatment for men with advanced prostate cancer? We all know the answer, it is hormone therapy. Almost without exception, when we get diagnosed, we are put on to hormone therapy (ADT). [...]
The FDA Has Granted A Special Protocol Assessment for Phase 3 Trial of PROSTVAC® – An On the Horizon Drug
Bavarian Nordic A/S today announced that they have received a letter of concurrence from the U.S. Food and Drug Administration (FDA) on a Special Protocol Assessment (SPA) for a Phase 3 study required for product [...]